JP Morgan Chase’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,600
Closed -$148K 5661
2018
Q2
$148K Hold
3,600
﹤0.01% 4691
2018
Q1
$209K Sell
3,600
-16,400
-82% -$959K ﹤0.01% 4354
2017
Q4
$1.09M Buy
+20,000
New +$1.02M ﹤0.01% 3677

Other funds holding ALKS

JP Morgan Chase's ALKS Position: Q2 2026 in Review

JP Morgan Chase reduced its Alkermes (ALKS) stake by 94% in Q2 2026, selling an estimated $150M and leaving 262,721 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

JP Morgan Chase first reported a position in ALKS in Q2 2013 and has held it in 49 quarters since. The position peaked at $173M in Q1 2025. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • JP Morgan Chase held 262,721 shares of Alkermes worth $14.2M as of Q2 2026.
  • JP Morgan Chase sold 3,839,068 Alkermes shares in Q2 2026, an estimated $150M.
  • Alkermes made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2498 holding.
  • JP Morgan Chase first reported a position in Alkermes in Q2 2013 and has held it in 49 quarters since.
  • JP Morgan Chase's Alkermes position peaked at $173M in Q1 2025.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.